J Zhang
- Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialBy E Pizzichini, JA Leff, TF Reiss, L Hendeles, LP Boulet, LX Wei, AE Efthimiadis, J Zhang and FE HargreaveE PizzichiniJA LeffTF ReissL HendelesLP BouletLX WeiAE EfthimiadisJ Zhang
- What are minimal important changes for asthma measures in a clinical trial?By NC Santanello, J Zhang, B Seidenberg, TF Reiss and BL BarberNC SantanelloJ ZhangB SeidenbergTF Reiss
- Measurement characteristics of two asthma symptom diary scales for use in clinical trialsBy NC Santanello, BL Barber, TF Reiss, BS Friedman, EF Juniper and J ZhangNC SantanelloBL BarberTF ReissBS FriedmanEF Juniper
- Kinin generation in acute pneumonia and chronic bronchitisBy M Zhang, B Peng, J Niehus, CR Baumgarten, T Brunnee, S Thalhofer, P Dorow and G KunkelM ZhangB PengJ NiehusCR BaumgartenT BrunneeS ThalhoferP Dorow
- Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study GroupBy MJ Noonan, P Chervinsky, M Brandon, J Zhang, S Kundu, J McBurney and TF ReissMJ NoonanP ChervinskyM BrandonJ ZhangS KunduJ McBurney
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.